52

Phaarmasia LtdBOM 523620

Последний отчетный период 30 сент., 2023

Обновлено 20 сент., 2024

Последняя цена

Капитализация млрд. $

0.002

Micro

Биржа

XBOM - Bombay Stock Exchange

Анализ акций 523620.BO

52

Нет оценки

Количественный анализ Eyestock не покрывает акции Phaarmasia Ltd.

Капитализация млрд. $

0.002

Дивидендная доходность

Оборот

6.83 млрд

Сайт компании

http://phaarmasia.in/

Phaarmasia Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The firm manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include hormone products and herbal products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.

Смотреть Секцию: Рейтинг